Welcome to the web site for the Life Sciences Consortium (LSC), a task force of the CEO Roundtable on Cancer. The LSC was formed in 2005 as a means of bringing together selected CEO Roundtable on Cancer Member companies to build collaboration that enables a transformation in research and development activities that will deliver more effective therapies to patients faster. Our hope is that visitors will use these resources and share their own relevant insights in a collaborative effort to better serve cancer patients worldwide.

"Ultimately, we know that as much as has been done, there is a lot of need for new treatments… and new hope. The Life Sciences Consortium is a powerful group that we can leverage. If companies and organizations come together in a collaborative way, then we can move the ball down the field a lot faster on oncology research."

Christopher A. Viehbacher
Chairman, CEO Roundtable on Cancer

S.T.A.R.T.

Access to standardized legal language for Key elements can increase the efficiency of contract negotiations, resulting in reduced costs and accelerating the entry of new therapies into clinical trials.

Search form

S.T.A.R.T.

Front Slider